Pharma Marketing Network
JULY 24, 2025
Due to strict FDA guidelines, pharma marketers also need to monitor conversations for adverse events, off-label discussions, and misinformation. What sets pharma apart is the need for analytics platforms that are HIPAA-compliant and can integrate medical lexicons and terminology into sentiment analysis.
Pharma Marketing Network
JULY 23, 2025
Much of the data used in AI models—like browsing behavior, health-related searches, or CRM entries—can be considered sensitive under regulations like HIPAA, GDPR, or CCPA. Regulatory agencies like the FDA, FTC, and EMA are watching closely to ensure that AI-driven tactics do not violate consumer privacy or promote off-label uses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MARCH 27, 2025
The emergence of HIPAA-compliant targeting technologies, HCP-specific segments, and improved analytics has made social platforms not just viable but essential for pharmaceutical marketing. While off-label promotion is still strictly regulated, unbranded awareness campaigns have found creative footing. It’s a strategic pillar.
Pharma Marketing Network
MARCH 8, 2025
Leverage first-party data to refine retargeting strategies while maintaining HIPAA compliance. FDA and HIPAA Compliance in PPC Fair balance requirements Ads must include benefits and risks equally. No unapproved drug claims All claims must be backed by clinical research and FDA-approved labeling.
Pharma Marketing Network
JUNE 15, 2025
For starters, every email must comply with HIPAA, CAN-SPAM, and FDA regulations. Missteps in off-label promotion or data security can trigger legal and reputational risks. While email remains a powerful tool for engaging healthcare professionals and patients, it’s subject to unique constraints.
Pharma Marketing Network
JUNE 23, 2025
HIPAA regulations, FDA guidelines, and state-level data privacy laws require careful consideration. Ad creatives must be approved by legal and medical review teams to meet FDA labeling requirements. Yes, when executed with anonymized data and reviewed creative, RTB can meet HIPAA and FDA guidelines.
Pharma Marketing Network
MARCH 31, 2025
As automation becomes smarter, ensuring HIPAA and GDPR compliance remains critical. Leveraging tools that enable real-time content approval and centralized tracking can prevent outdated messaging or off-label promotion. However, marketers must balance innovation with privacy.
Expert insights. Personalized for you.
Let's personalize your content